SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001193125-24-099263
Filing Date
2024-04-17
Accepted
2024-04-17 17:26:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B d783331d8a12b.htm 8-A12B 33903
  Complete submission text file 0001193125-24-099263.txt   34956
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-34186 | Film No.: 24852085
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)